Lunai Bioworks Inc. (LNAI)
NASDAQ: LNAI · Real-Time Price · USD
0.362
-0.020 (-5.12%)
At close: Mar 5, 2026, 4:00 PM EST
0.354
-0.007 (-2.05%)
Pre-market: Mar 6, 2026, 9:01 AM EST
Lunai Bioworks Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Selling, General & Admin | 12.4 | 17.88 | 24.56 | 15.32 | 14.33 | 7.56 | |
| Research & Development | 0.06 | 0.54 | 2.71 | 4.17 | 8.37 | 15.72 | |
| Operating Expenses | 12.58 | 18.55 | 27.39 | 19.6 | 22.83 | 23.4 | |
| Operating Income | -12.58 | -18.55 | -27.39 | -19.6 | -22.83 | -23.4 | |
| Interest Expense | -0.62 | -0.73 | -1.01 | -0.58 | -0.37 | -0.38 | |
| Interest & Investment Income | 0.05 | 0.12 | - | - | - | 0.01 | |
| Currency Exchange Gain (Loss) | - | - | - | -0 | 0 | -0.03 | |
| Other Non Operating Income (Expenses) | - | - | -1.42 | -0.13 | 0.12 | - | |
| EBT Excluding Unusual Items | -13.15 | -19.16 | -29.82 | -20.3 | -23.08 | -23.8 | |
| Impairment of Goodwill | -122.8 | -170.42 | -11.64 | - | - | - | |
| Gain (Loss) on Sale of Investments | 0.04 | -0.11 | - | - | - | - | |
| Asset Writedown | -0.83 | - | -42.61 | -18.96 | -93.25 | - | |
| Other Unusual Items | 11.22 | 11.68 | -4.35 | -0.42 | 2.9 | -3.05 | |
| Pretax Income | -125.52 | -178.01 | -88.43 | -39.68 | -113.43 | -26.85 | |
| Income Tax Expense | - | - | - | - | 0 | -0.13 | |
| Net Income | -125.52 | -178.01 | -88.43 | -39.68 | -113.43 | -26.72 | |
| Net Income to Common | -125.52 | -178.01 | -88.43 | -39.68 | -113.43 | -26.72 | |
| Shares Outstanding (Basic) | 20 | 17 | 10 | 6 | 5 | 5 | |
| Shares Outstanding (Diluted) | 20 | 17 | 10 | 6 | 5 | 5 | |
| Shares Change (YoY) | 37.73% | 69.27% | 73.31% | 7.12% | 11.37% | 1.81% | |
| EPS (Basic) | -6.27 | -10.78 | -9.07 | -7.05 | -21.59 | -5.67 | |
| EPS (Diluted) | -6.27 | -10.78 | -9.07 | -7.05 | -21.59 | -5.67 | |
| Free Cash Flow | -5.72 | -7.87 | -11.04 | -11.8 | -15.74 | -20.66 | |
| Free Cash Flow Per Share | -0.29 | -0.48 | -1.13 | -2.10 | -3.00 | -4.38 | |
| EBITDA | -12.46 | -18.42 | -27.27 | -19.48 | -22.7 | -23.28 | |
| D&A For EBITDA | 0.12 | 0.13 | 0.12 | 0.11 | 0.12 | 0.12 | |
| EBIT | -12.58 | -18.55 | -27.39 | -19.6 | -22.83 | -23.4 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.